The next step for sNPWT
Using Vivafoam for treatment of wounds with sligthly increased depth
VivereX®
At the first sigth seems to be similar to few other sNPWT, but
its behaivior is much different.
Patients’ experience
Female born 1944: Patient presented with a ventral hernia after a VBG which was performed 25 years ago, this has consequently led to an accumulation of wound fluid. The fluid has been drained on multiple occasions. VivereX was used and the wound was successfully closed after 2 days of treatment however, since there was additional fluid remaining, the wound had to be reopened and drained again. During the 2nd treatment session with VivereX, there was no addition sign of fluid retention and the wound fully healed after 4 days.
Male born 1952: Patient was diagnosed with blistering erysipelas during December 2020, 1.5 weeks later a wound debridement of necrotic tissue was performed of an area of 12X12 (cm). Initially, the wound was treated with a competing device. The wound size did not decreased, therefor the current device was replaced by VivereX. The patient expressed a substantial difference when compared to VivereX; he felt that there was less leakage and tension during treatment with VivereX.
Male, born 1948. Diabetic patient treated with combining insulin and oral drug therapy. Fell from a ladder on 12/8/2021 and an iron pipe penetrated his leg, which caused a 6X4 (cm) wound with a depth of 5 mm. On September 20th, 2021, a VivereX device was applied and 3 days later the wound size had decreased to 5X4 (cm) and with a depth of 2-3 mm. 8 days later the wound has further decreased to 3.5X3.5 cm and with a depth of 1mm. The wound fully closed during the first week of December 2021.